
Lithium Argentina AG
Metals & Mining
Lithium Argentina AG (LAR) Stock News
The latest LAR headlines and market coverage — 30 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Alarum Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Rosen Law Firm - ALAR
Rosen Law Firm has filed a class action lawsuit against Alarum Technologies Ltd. (NASDAQ: ALAR) on behalf of investors who purchased securities between March 20, 2025 and July 2, 2026. The lawsuit alleges that defendants made false and misleading statements regarding a subsidiary's illegal activity of linking customer home internet devices into another network without consent, which heightened legal exposure and threatened business prospects. Investors who purchased during the class period may be entitled to compensation.
- GlobeNewswire Inc.·
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Alarum Technologies Ltd. (ALAR)
A securities class action lawsuit has been filed against Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly failing to disclose that its subsidiary NetNut was engaging in illegal activity by linking customer home internet devices into another network without consent, enabling cybercriminals to conceal their locations. The lawsuit covers investors who purchased shares between March 20, 2025 and July 2, 2026.
- GlobeNewswire Inc.·
ROSEN, A LEADING NATIONAL FIRM, Encourages Alarum Technologies Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Rosen Law Firm - ALAR
Rosen Law Firm has filed a class action lawsuit against Alarum Technologies Ltd. (NASDAQ: ALAR) on behalf of investors who purchased securities between March 20, 2025 and July 2, 2026. The lawsuit alleges that defendants made false and misleading statements regarding a subsidiary's illegal activity of linking customer home internet devices into another network without consent, which heightened legal exposure and threatened business prospects. Investors with losses exceeding $100,000 are encouraged to seek counsel before the October 5, 2026 deadline to serve as lead plaintiff.
- GlobeNewswire Inc.·
ALARUM CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Alarum Technologies Ltd and Encourages Investors to Contact the Firm
A class action lawsuit has been filed against Alarum Technologies Ltd (NASDAQ: ALAR) for allegedly making false and misleading statements regarding its subsidiary NetNut's illegal activity of linking customer home internet devices to networks without consent. The complaint alleges this activity facilitated cybercriminal operations and materially heightened the company's legal exposure. Investors who purchased Alarum securities between March 20, 2025 and July 2, 2026 can join the lawsuit, with a lead plaintiff deadline of October 5, 2026.
- GlobeNewswire Inc.·
CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE JUILLET 2026
Crédit Agricole S.A. reports strong activity in Q2 2026 and announces acceleration of its AI transformation initiatives. The company maintains its capital structure with 3,025,902,350 total shares and 3,025,634,720 exercisable voting rights as of July 31, 2026.
- GlobeNewswire Inc.·
Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm has announced an investigation into Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized certain domains associated with its subsidiary NetNut Ltd. Following this disclosure, Alarum's stock fell 51.49% on July 6, 2026. The firm is preparing a class action lawsuit to recover investor losses.
- GlobeNewswire Inc.·
Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm announced an investigation into potential securities claims against Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized domains associated with its subsidiary NetNut Ltd. The stock fell 51.49% on July 6, 2026, following the announcement. The firm is preparing a class action lawsuit to recover investor losses.
- The Motley Fool·
The CLARITY Act Is Moving Again in the Senate. Here's What Passage Would Change for Coinbase and Robinhood.
The CLARITY Act, which aims to establish a clear federal framework for regulating digital assets, is being revised in the Senate with a potential vote after mid-September. Passage could benefit Coinbase and Robinhood by allowing stablecoin yields and shifting crypto oversight to the CFTC, though the author favors Robinhood as a safer long-term investment due to its diversification and steadier growth compared to Coinbase's tight dependence on the crypto market.
- GlobeNewswire Inc.·
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Alarum Technologies, Inc. (NASDAQ: ALAR)
Law firm Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Alarum Technologies following the FBI seizure of domains associated with its subsidiary NetNut Ltd. The company disclosed the seizures on July 2-3, 2026, citing potential disruptions to services and possible misuse of its network. Alarum's stock price plummeted from $8.02 on July 1 to $3.08 by July 6, 2026.
- GlobeNewswire Inc.·
Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm announced an investigation into potential securities claims against Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized domains associated with its subsidiary NetNut Ltd. The stock fell 51.49% on July 6, 2026, following the announcement. The firm is preparing a class action lawsuit to recover investor losses.
- GlobeNewswire Inc.·
Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm announced an investigation into potential securities claims against Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized domains associated with its subsidiary NetNut Ltd. The stock fell 51.49% on July 6, 2026, following the announcement. The firm is preparing a class action lawsuit to recover investor losses.
- GlobeNewswire Inc.·
Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm announced an investigation into potential securities claims against Alarum Technologies Ltd. (NASDAQ: ALAR) following allegations of materially misleading business information. On July 2, 2026, Alarum disclosed that the FBI seized domains associated with its subsidiary NetNut Ltd. The stock fell 51.49% on July 6, 2026. The firm is preparing a class action lawsuit to recover investor losses.
- GlobeNewswire Inc.·
Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm announced an investigation into Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026 that the FBI seized domains associated with its subsidiary NetNut Ltd. The stock fell 51.49% on July 6, 2026. The firm is preparing a class action lawsuit to recover investor losses.
- GlobeNewswire Inc.·
CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE JUIN 2026
Crédit Agricole S.A. announced two significant partnership developments: the acquisition of 100% of CAWL from Worldline, and a long-term partnership agreement with BCC-Grupo Cajamar. These moves represent the evolution of Crédit Agricole's strategic partnerships and expansion initiatives.
- GlobeNewswire Inc.·Neutral
CLARIANE PRE Stabilization Notice
BNP Paribas announces a pre-stabilisation period for CLARIANE SE's EUR 333 million perpetual undated subordinated fixed rate resettable notes offering. The stabilisation period is expected to run from June 23, 2026 to July 29, 2026, with multiple stabilisation managers appointed to support the market price of the securities during this period.
- Benzinga·
THOR INDUSTRIES ANNOUNCES REGULAR QUARTERLY DIVIDEND
Thor Industries' Board of Directors approved a regular quarterly cash dividend of $0.52 per share, payable on July 15, 2026, to shareholders of record as of July 1, 2026. The company is the world's largest manufacturer of recreational vehicles.
- Benzinga·
DOLLARAMA REPORTS FISCAL 2027 FIRST QUARTER RESULTS
MONTREAL , June 11, 2026 /CNW/ - Dollarama Inc. (TSX: DOL ) ("Dollarama" or the "Corporation") today reported its financial results for the first quarter ended May 3, 2026. Refer to "Selected Segmented Financial Information" on page 6 of this press release for additional information regarding the Corporation's Canadian and Australian reportable segments. Fiscal 2027 First Quarter Results Highlights Compared to Fiscal 2026 First Quarter Sales increased by 21.4% to $1,846.1 million, compared to $1,521.2 million Comparable store sales (1) in Canada increased by 5.6%, compared to 4.9% in the first quarter of the previous year EBITDA (1) increased by 17.4% to $582.5 million, representing an EBITDA margin (1) of 31.6%, compared to 32.6% Operating income increased by 11.2% to $432.2 million, representing an operating margin (1) of 23.4%, compared to 25.6% Net earnings increased by 10.4% to $302.3 million, resulting in a 13.3% increase in diluted net earnings per common share to $1.11, compared to $0.98 Unrealized gain of $16.4 million relating to the derivative on our equity-accounted investments, positively impacting EBITDA margin by 90 basis points and diluted net earnings per common share by $0.06 28 net new stores opened in Canada, compared to 22 in the corresponding period of the previous year; 8 net new stores opened and 13 stores renovated in Australia, all operating under the legacy banner 1,962,010 common shares repurchased for cancellation for $339.1 million "We delivered a strong performance in the first quarter of fiscal 2027 as we pursue profitable growth in our core Canadian market, generating strong comparable store sales growth, expanding our store network and progressing our Western Canada logistics hub project. We are also advancing our priorities across our international growth platforms with discipline. In Latin America, Dollarcity had a solid start to th
- GlobeNewswire Inc.·
Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses
Kymera Therapeutics announced preclinical data for KT-579, an oral IRF5 degrader, demonstrating disease-modifying activity in lupus models comparable or superior to approved therapies. The compound showed consistent activity across multiple disease pathways including Type I interferons and pro-inflammatory cytokines. Phase 1 healthy volunteer trial is ongoing with data expected in the second half of 2026, followed by a planned patient proof-of-concept trial in lupus.
- GlobeNewswire Inc.·
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
Cullinan Therapeutics announced positive Phase 1 clinical data for CLN-978, a CD19xCD3 T cell engager, showing clinical benefit including remissions in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following single target doses. The drug demonstrated deep, dose-dependent B cell depletion with a favorable safety profile. The company will present additional data and host an Immunology Day on June 10 to discuss CLN-978 and initial data for velinotamig, a BCMAxCD3 T cell engager.
- GlobeNewswire Inc.·
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
Immutep announced positive Phase I interim data for IMP761, a first-in-class LAG-3 agonist antibody for autoimmune diseases. The study met its primary endpoint, demonstrating favorable safety and tolerability in healthy volunteers, with statistically significant pharmacodynamic activity at 7 mg/kg dose. The results support further clinical investigation in autoimmune indications such as rheumatoid arthritis.
- Benzinga·
TOURMALINE DECLARES QUARTERLY DIVIDEND AND ANNOUNCES ELECTION OF DIRECTORS
Tourmaline Oil Corp. announced a quarterly cash dividend of $0.50 per share payable on June 30, 2026, and held its annual shareholder meeting on June 3, 2026, where ten directors were elected. The company is Canada's largest natural gas producer focused on low-cost development in the Western Canadian Sedimentary Basin.
- Benzinga·
VERSABANK DECLARES DIVIDENDS
VersaBank (NASDAQ: VBNK) announced a quarterly cash dividend of CAD $0.025 per common share, payable July 31, 2026, to shareholders of record as of July 10, 2026. The dividends are eligible for tax purposes.
- GlobeNewswire Inc.·Neutral
Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026
Levicept Ltd presented Phase II clinical trial data for LEVI-04, a first-in-class neurotrophin-3 inhibitor for osteoarthritis treatment, at the EULAR conference in London. The study of 518 patients demonstrated significant dose-dependent reductions in bone marrow lesions, clinically meaningful improvements in pain and function comparable to NSAIDs, and a differentiated safety profile compared to anti-NGF therapies.
- GlobeNewswire Inc.·
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
Zenas BioPharma announced that obexelimab met its primary and all key secondary endpoints in the Phase 3 INDIGO trial for Immunoglobulin G4-Related Disease (IgG4-RD). The drug demonstrated a 56% reduction in flare risk, 65% reduction in glucocorticoid use, and favorable safety profile comparable to placebo. A Biologics License Application (BLA) was submitted to the FDA in May 2026, with results presented at EULAR 2026 Congress and published in the New England Journal of Medicine.
- GlobeNewswire Inc.·
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm
Law firm Bragar Eagel & Squire is investigating Claritev Corporation following a DOJ criminal price-fixing investigation into the company's Data iSight pricing tool, reported by The Capitol Forum on May 14, 2026. The announcement triggered a sharp 41% stock price decline, dropping from $23.47 to $13.87 per share. The firm is seeking stockholders who suffered losses to discuss potential legal claims.
- Benzinga·Neutral
JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS
John Hancock Investment Management announced quarterly distributions for four closed-end funds on June 1, 2026. The funds declared distributions ranging from $0.1535 to $0.6500 per share, with payment scheduled for June 30, 2026. Distributions may include net investment income, capital gains, and return of capital.
- Benzinga·Neutral
JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS
John Hancock Investment Management announced monthly distributions for its closed-end funds on June 1, 2026. The Tax-Advantaged Dividend Income Fund (HTD) will distribute $0.1580 per share monthly, while the Premium Dividend Fund (PDT) will distribute $0.0825 per share monthly. All distributions are scheduled for payment on June 30, 2026.
- Benzinga·
STEWART INFORMATION SERVICES CORPORATION DECLARES SECOND QUARTER DIVIDEND
Stewart Information Services Corporation (NYSE: STC) announced a cash dividend of $0.525 per share for Q2 2026, payable on June 30, 2026, to shareholders of record as of June 15, 2026. The global real estate services company continues its dividend distribution to common stockholders.
- Benzinga·
TD BANK GROUP DECLARES DIVIDENDS
Toronto-Dominion Bank announced a quarterly dividend of $1.12 per common share payable July 31, 2026, to shareholders of record as of July 10, 2026. The bank also declared dividends on three series of preferred shares. Shareholders can participate in the Dividend Reinvestment Plan to have dividends automatically reinvested in additional common shares purchased on the open market.
- Benzinga·
FLANIGAN'S DECLARES DIVIDEND
Flanigan's Enterprises, Inc. (AMEX: BDL), owner and operator of Flanigan's Seafood Bar and Grill restaurants and Big Daddy's retail liquor stores, announced a cash dividend of $0.60 per share to shareholders of record on June 10, 2026, payable on June 26, 2026.